![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Albany Molecular Says Bristol-Myers Stops Development of Depression Drug
Albany Molecular Says Bristol-Myers Stops Development of Depression Drug
August 13, 2013
Albany Molecular has announced that its partner, Bristol-Myers Squibb, has stopped developing a depression drug that the two were working on jointly.
Reuters
Reuters
Upcoming Events
-
21Oct